financetom
Business
financetom
/
Business
/
Analysis-Labubu resale price falls may be more about supply than demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Analysis-Labubu resale price falls may be more about supply than demand
Oct 22, 2025 1:32 AM

SHANGHAI (Reuters) -Kasidit Teerawiboosin, 22, has ridden the wave of Labubu's success as a reseller in Thailand of toys from Pop Mart ( POPMF ), but the days of easily making money flipping the toothy-grinned monsters are numbered.

"Prices in the Thai resale market are going down really, really, really fast," said Teerawiboosin, who has been buying Pop Mart ( POPMF ) toys and selling them on unopened since early 2024.

Labubu are part of Pop Mart's ( POPMF ) "The Monsters" series of toys which accounted for more than a third of first-half revenue, as sales soared thanks to the influence of celebrity fans such as Lisa of K-pop group Blackpink, singer Rihanna and ex-soccer star David Beckham.

That has led to a booming resale market, supporting prices of both the toys and Pop Mart ( POPMF ) stock. But resale prices worldwide have dropped since their summer peak, raising questions about the longevity of demand for the Chinese toymaker's cash cow.

Data from Chinese art toy resale platform Qiandao showed the price of Labubu character "Luck", launched in April, peaked in June above 500 yuan ($70.20) on the secondary market but is now around 108 yuan. Prices of other characters in the same series have fallen below those at official Pop Mart ( POPMF ) stores.

Investors have been quick to pin the fall in resale prices on cooling demand, with Pop Mart's ( POPMF ) share price down around 25% since August highs, though analysts and the company itself have said that the issue is supply rather than demand.

The stock is still up 186% year to date.

Pop Mart ( POPMF ) said it has increased supply of plush toys, including Labubu, by 10 times this year and that it produces around 30 million units a month.

"It's similar to concert tickets," said Sid Si, Pop Mart's ( POPMF ) executive director and co-COO, in response to Reuters' questions about Labubu's resale value. "Fans often end up scrambling for overpriced resold concert tickets because venues can't simply add more seats to meet surging demand, but for Pop Mart ( POPMF ), there's a crucial difference - we can proactively increase supply to ease demand pressure."

A summer sales boom means it is almost impossible to buy a Labubu from a Pop Mart ( POPMF ) store. Falling resale prices, then, could "potentially" indicate satisfied demand but also more supply considering resellers likely made up a significant portion of first market sales, said Morningstar analyst Jeff Zhang.

Resale demand may therefore not be the primary concern. Investors "may also incorporate a higher risk premium for Pop Mart's ( POPMF ) earnings if revenue growth peaks in this year," he said.

Pop Mart's ( POPMF ) revenue grew as much as 250% in July-September, outpacing the 204.4% growth of the first half of the year, a stock exchange filing showed.

Morgan Stanley analysts, in a September client note, said "prices in the second-hand market do not effectively reflect the true supply and demand situation" especially given Pop Mart's ( POPMF ) effort to limit scalping this year and "overly relying on this indicator may lead to misleading conclusions".

Up-and-coming characters such as "Twinkle Twinkle" and scope for international expansion remain important factors for Pop Mart's ( POPMF ) growth, Morgan Stanley analysts said.

With Pop Mart ( POPMF ) opening its largest store in Bangkok in August, Teerawiboosin also links the fall in resale value to an increase in Pop Mart's ( POPMF ) direct-to-consumer business, prompting resellers in Thailand to look overseas for new sales channels.

"Resellers are starting to export to other countries, especially like Europe or Russia - places that don't have official Pop Mart ( POPMF ) stores," he said.

($1 = 7.1230 Chinese yuan renminbi)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved